LFMD LIFEMD INC

LifeMD to Participate in Three Investor Conferences During September

LifeMD to Participate in Three Investor Conferences During September

NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of September:

  • Cantor Fitzgerald Global Healthcare Conference, September 3-5 at the New York Marriott Marquis. Management will participate in a fireside chat on Wednesday, September 3rd at 8:35 a.m. Eastern time and will be available for one-on-one meetings with investors.

  • H.C. Wainwright 27th Annual Global Investment Conference, September 8-10 at the Lotte New York Palace Hotel. LifeMD’s virtual corporate presentation will be available on demand beginning Friday September 5th to conference participants. Management will hold one-on-one meetings with investors throughout the conference.

  • Lake Street Capital Markets 9th Annual Best Ideas Growth Conference, September 11 at The Yale Club of New York City. Management will be holding one-on-one meetings with investors.

About LifeMD, Inc.

LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit .

Investor Contact

Marc Benathen, Chief Financial Officer

Media Contact

Jessica Friedeman, Chief Marketing and Product Officer



EN
28/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LIFEMD INC

 PRESS RELEASE

LifeMD Offers Ozempic® at $499 Per Month through Collaboration with No...

LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk Ozempic® is now available at this reduced price to eligible self-pay LifeMD patients NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care, today announced an additional offering through its collaboration with Novo Nordisk that provides access to Ozempic® (semaglutide), a GLP-1 RA for patients with type 2 diabetes, at $499 per month. Through LifeMD’s integration with NovoCare® Pharmacy, eligible self-pay and uninsured patients, as well as insured patients w...

 PRESS RELEASE

LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities ...

LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the ROTH 4th Annual Healthcare Opportunities Conference, which will be held October 9, 2025 at the Metropolitan Club in New York City. Management will hold one-on-one meetings with investors throughout the day. Investors can register for the conference by contacting their ROTH Capital Partners representative. About LifeMD, Inc. LifeMD® is a leading provider...

 PRESS RELEASE

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Pr...

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on October 15, 2025, to holders of record at the close of business on October 3, 2025. About LifeMD, Inc.LifeMD® is a leading provider of virtual primary c...

 PRESS RELEASE

LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliv...

LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at Scale Enhanced Affiliated Pharmacy Capabilities Support Specialized Therapies, Seamless Patient Experience, and Margin Expansion NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the expansion of its state-of-the-art affiliated pharmacy to include advanced non-sterile compounding capabilities for oral and topical medications. This milestone extends LifeMD’s pharmacy growth strategy by enabling ...

 PRESS RELEASE

LifeMD to Participate in Three Investor Conferences During September

LifeMD to Participate in Three Investor Conferences During September NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of September: Cantor Fitzgerald Global Healthcare Conference, September 3-5 at the New York Marriott Marquis. Management will participate in a fireside chat on Wednesday, September 3rd at 8:35 a.m. Eastern time and will be available for one-on-one meetings with investors.H.C. Wainwright 27th Annual Gl...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch